About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 195   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

  Table of Contents 
Year : 2019  |  Volume : 26  |  Issue : 1  |  Page : 53  

Authors' Reply

Ocular Oncology Service and Department of Pathology, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA

Date of Web Publication24-Apr-2019

Correspondence Address:
Dr. Carol L Shields
Ocular Oncology Service, 840 Walnut Street, Suite 1440, Philadelphia, PA
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/meajo.MEAJO_294_18

Rights and Permissions

How to cite this article:
Pennington JD, Welch R J, Lally SE, Shields JA, Eagle RC, Shields CL. Authors' Reply. Middle East Afr J Ophthalmol 2019;26:53

How to cite this URL:
Pennington JD, Welch R J, Lally SE, Shields JA, Eagle RC, Shields CL. Authors' Reply. Middle East Afr J Ophthalmol [serial online] 2019 [cited 2020 Aug 13];26:53. Available from: http://www.meajo.org/text.asp?2019/26/1/53/256989


We thank the author for the insightful comments on the potential relationship of HIV with rhabdomyosarcoma. In our case, prior to commencing chemotherapy, the patient's immune status was carefully examined and our patient was HIV negative. We agree that the overlap between cancer and the immune system is fertile ground for our understanding of the pathogenesis, progression, and possible cure of cancer. [1,2]

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. Checkpoint inhibitor immune therapy: Systemic indications and ophthalmic side effects. Retina 2018;38:1063-78.   Back to cited text no. 1
Shields CL, Chien JL, Surakiatchanukul T, Sioufi K, Lally SE, Shields JA, et al. Conjunctival tumors: Review of clinical features, risks, biomarkers, and outcomes - The 2017 J. Donald M. Gass Lecture. Asia Pac J Ophthalmol (Phila) 2017;6:109-20.  Back to cited text no. 2


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article

 Article Access Statistics
    PDF Downloaded30    
    Comments [Add]    

Recommend this journal